Candel Therapeutics (CADL) Net Income: 2020-2023
Historic Net Income for Candel Therapeutics (CADL) over the last 4 years, with Dec 2023 value amounting to -$5.4 million.
- Candel Therapeutics' Net Income rose 31.61% to -$5.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$33.7 million, marking a year-over-year increase of 3.54%. This contributed to the annual value of -$30.2 million for FY2024, which is 10.44% up from last year.
- According to the latest figures from Q4 2023, Candel Therapeutics' Net Income is -$5.4 million, which was up 40.34% from -$9.0 million recorded in Q3 2023.
- Candel Therapeutics' 5-year Net Income high stood at -$2.4 million for Q2 2020, and its period low was -$9.8 million during Q2 2023.
- In the last 3 years, Candel Therapeutics' Net Income had a median value of -$8.5 million in 2021 and averaged -$7.9 million.
- As far as peak fluctuations go, Candel Therapeutics' Net Income slumped by 197.01% in 2021, and later soared by 31.61% in 2023.
- Over the past 4 years, Candel Therapeutics' Net Income (Quarterly) stood at -$6.1 million in 2020, then dropped by 27.57% to -$7.8 million in 2021, then declined by 1.60% to -$7.9 million in 2022, then soared by 31.61% to -$5.4 million in 2023.
- Its Net Income was -$5.4 million in Q4 2023, compared to -$9.0 million in Q3 2023 and -$9.8 million in Q2 2023.